Literature DB >> 26408991

Mechanical Symptoms of Osteoarthritis in the Knee and Arthroscopy.

Metin Tolga Buldu1, Jennifer L Marsh2, Jamie Arbuthnot3.   

Abstract

The potential benefit of arthroscopy as a treatment for knee osteoarthritis is contentious, with National Institute for Health and Care Excellence stating that, "There is uncertainty regarding the efficacy of the procedure." This is a study of a consecutive series of patients with osteoarthritis of the knee, suffering from mechanical symptoms, such as giving way, catching, and locking, and undergoing arthroscopic debridement, including chondroplasty and meniscectomy where appropriate. A total of 33 patients were reviewed at a mean period of 24 months (standard deviation 3 months) and follow-up data were obtained for 28 of these patients. Primary outcomes measured were: number of mechanical symptom episodes per week and visual analog scores for pain. Secondary outcomes measured were: Oxford, Lysholm, and Tegner knee scores together with arc of motion of the joint. Seven patients went on to have a knee replacement within 2 years. In the patient subgroup who did not require further surgery, there was statistically significant improvement in giving way (p = 0.0184) and marginally significant improvement in catching and locking (p = 0.1105 and p = 0.087, respectively). There were statistically significant improvements found in the Oxford and Lysholm scores (p < 0.0001). An average decrease of 1.9 in the VAS pain score was observed that was also statistically significant (p < 0.0007) and an average improvement of 10 degrees in the arc of motion was noted, which was marginally significant (p = 0.0687). To our knowledge, this is the first study with a primary outcome measure of mechanical symptoms experienced by patients. The results overall suggest that patient symptoms improved following arthroscopic treatment. As a result, episodes of mechanical symptoms should be important criteria for clinicians in determining the patient suitability for arthroscopic debridement. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2015        PMID: 26408991     DOI: 10.1055/s-0035-1564592

Source DB:  PubMed          Journal:  J Knee Surg        ISSN: 1538-8506            Impact factor:   2.757


  7 in total

1.  Incidence and predictors of total knee arthroplasty following knee arthroscopy.

Authors:  Tristan Camus; Jiho Han; Feroz Osmani; Norman Scott; William J Long
Journal:  J Orthop       Date:  2017-11-06

2.  Changes Within Clinical Practice After a Randomized Controlled Trial of Knee Arthroscopy for Osteoarthritis.

Authors:  Nirav H Amin; Waqas Hussain; John Ryan; Shannon Morrison; Anthony Miniaci; Morgan H Jones
Journal:  Orthop J Sports Med       Date:  2017-04-10

3.  Optimization of TGF-β1-transduced chondrocytes for cartilage regeneration in a 3D printed knee joint model.

Authors:  Jiyong Ahn; Seon Ae Kim; Ki Won Kim; Joon Hyuck Oh; Seok Jung Kim
Journal:  PLoS One       Date:  2019-05-23       Impact factor: 3.240

4.  Arthroscopic Arthroplasty for Knee Osteoarthritis: Denervation of Subchondral Bone and Comprehensive Synovectomy.

Authors:  Jinzhong Zhao
Journal:  Arthrosc Tech       Date:  2021-11-09

5.  Prognostic factors for the treatment of meniscus horizontal tear.

Authors:  Joon Kyu Lee; Myung Chul Lee; Joong Il Kim; Subin Lim
Journal:  Sci Rep       Date:  2022-10-14       Impact factor: 4.996

6.  Effect of medial meniscus extrusion on arthroscopic surgery outcome in the osteoarthritic knee associated with medial meniscus tear: a minimum 4-year follow-up.

Authors:  Yu-Xing Wang; Zhong-Li Li; Ji Li; Zhi-Dong Zhao; Hao-Ran Wang; Cheng Hou; Wei Li; Chun-Hui Liu
Journal:  Chin Med J (Engl)       Date:  2019-11-05       Impact factor: 2.628

7.  Non-Surgical Treatment of Knee Osteoarthritis: Multidisciplinary Italian Consensus on Best Practice.

Authors:  Lorenzo Pradelli; Tiziana Sinigaglia; Alberto Migliore; Giovanni Antonio Checchia; Francesco Franceschi; Bruno Frediani; Florenzo Iannone; Emilio Romanini
Journal:  Ther Clin Risk Manag       Date:  2021-05-28       Impact factor: 2.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.